Nowadays, the pathophysiological perspective outlines neuronal dysfunction as a predisposing factor to migraine attack onset, with secondary involvement of the vascular system. The cortical excitability of the migraine brain is different from the not migraine one, with a critical unbalance between excitatory and inhibitory neurotransmission, fluctuating across migraine phases. A genetic predisposition to such brain dysfunction [
4,
5], could facilitate the attack onset. It is unclear how a typical migraine attack is triggered—this is one of the most important unanswered questions in migraine neuroscience. Precipitating factors are environmental, as light, sounds and odors, emotional, or endogenous, depending on the general state of health. The triggers likely vary between and within subjects [
6], depending on pre-existing network characteristics that might be quite individual. A thalamus-cortical dysrhythmia could be the pivotal abnormality causing the altered response to the multimodal stimuli [
7]. The role of hypothalamus in determining abnormal adaptation to environmental conditions has been recently recognized [
8]. Different migraine phases, the inter-critic, prodromal, acute and post-acute, are the expression of the fluctuation of brain functional state, which could be measured with different analysis [
9]. Altered connectivity within cortical-subcortical circuits [
10], defined an important dysfunctional aspect of migraine, with different connections within the default mode network [
11], as well as the visual and pain-related cortical complex [
12,
13]. The complex interictal dysfunction of migraine brain, could culminate in the phenomenon of Cortical Spreading Depression (CSD). Since the pivotal study of Hadjikhani et al. [
14], CSD is considered to be the physiological substrate of the migraine aura, and even of migraine without aura, that causes the spreading of a self-propagating wave of cellular depolarization in the cerebral cortex [
15]. This bioelectrical phenomenon is followed in a causal mode by the activation of the trigemino-vascular system, with antidromic recruitment of meningeal vessels, vassal dilation and inflammatory neurotransmitters extravasation. This auto-induced sterile inflammation stimulates in turn trigeminal caudal nucleus and cervical C1–C3 roots [
16]. The painful inputs from a-delta and C trigeminal and cervical afferents, reach the VPL and PO thalamus nuclei, the primary and secondary somatosensory cortex, the insula and the associative cortex, comprised in the so-called pain matrix or salience matrix network [
17]. Calcitonin Gene-Related Peptide (CGRP), Substance P and nitric oxide are the main substances in the inflammatory process. The antagonistic action on CGRP receptors is thus a mode to cause an interruption of headache generation via a peripheral inhibition of the nociceptive system. Craniofacial afferents that synapse in the trigemino-cervical system project, directly or indirectly, to structures involved in the sensory/discriminatory, salience/alerting, and affective/motivational aspects of pain, as well as to structures involved in the response to pain-reflex autonomic and descending facilitatory/inhibitory modulation [
18]. A dysfunction of descending pain modulation system, and probably basal hyperactivity of nociceptive neuron within the trigeminal caudal and C1–C3 nuclei, facilitate central sensitization phenomenon, allodynia generation, and neuronal plastic changes that render migraine patients prone to headache maintenance and persistence in a chronic mode [
19]. The great challenge for the migraine approach is the understanding of the theoretic basis of the long-term effect of peripheral interaction via CGRP inhibition on the complex central dysfunction which could account for migraine inclusion within the “oscillopathies”. The complexity of brain function is based on dynamic relationships among cortical and subcortical areas, which enable the brain to adapt itself to different physiological and pathological conditions, a feature possibly affected in the migraine brain [
20].